Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management

Published:2022-05-28 Issue:8 Volume:24 Page:643-654
ISSN:1523-3804
Container-title:Current Atherosclerosis Reports
language:en
Short-container-title:Curr Atheroscler Rep

Author:

Taha Mohamad B.,Yahya Tamer,Satish Priyanka,Laird Rachel,Agatston Arthur S.,Cainzos-Achirica Miguel,Patel Kershaw V.,Nasir Khurram

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11883-022-01041-7.pdf

Reference84 articles.

1. Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, Long MW, Gortmaker SL. Projected U.S. State-level prevalence of adult obesity and severe obesity. New Englan J Med. 2019;381:2440–50.

2. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347:59–60.

3. Bogers RP, Bemelmans WJE, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, Van Dam RM, Hu FB, Visscher TLS, Menotti A, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167:1720–8.

4. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386:154–62.

5. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G, Selmer R, Strand BH, Dobson A, Hozawa A, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014;383:970–83.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension;Clinical Hypertension;2024-09-01

2. A Very Rare Cause of Markedly Elevated CA 19-9: Glucagon-like Peptide-1 Receptor Agonists;Diabetes & Metabolism;2024-09

3. Bridging the Gap: A Literature Review of Advancements in Obesity and Diabetes Mellitus Management;Applied Sciences;2024-07-27

4. Glucagon-like Peptide 1 Receptor Agonists Promote Weight Loss Among People With Human Immunodeficiency Virus;Clinical Infectious Diseases;2024-03-19

5. Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on “time in range” in patients with type 2 diabetes;Frontiers in Pharmacology;2024-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3